Copy the page URI to the clipboard
Missailidis, Sotiris and Perkins, Alan
(2005).
DOI: https://doi.org/10.1159/000090902
URL: http://content.karger.com/ProdukteDB/produkte.asp?...
Abstract
Introduction: Molecular targeted therapeutics offers high target affinity, specificity and improved therapeutic
potential with reduced side effects. The traditional use of antibodies has presented problems associated with
production, purification, immunogenicity and size, whereas small peptides have reduced affinities and specificities. Aptamers can be generated rapidly against targets, showing a better tumour penetration, rapid uptake and clearance, thus providing effective vehicles for cytotoxic agents.
Viewing alternatives
Metrics
Public Attention
Altmetrics from AltmetricNumber of Citations
Citations from DimensionsItem Actions
Export
About
- Item ORO ID
- 3905
- Item Type
- Journal Item
- ISSN
- 1010-4283
- Extra Information
- Tumor Biology Supplement 1, 2006 - Cancer Research, Tumor Markers, Clinical Oncology
- Keywords
- aptamer; targeted radiopharmaceuticals; tumour imaging; cancer therapy
- Academic Unit or School
-
Faculty of Science, Technology, Engineering and Mathematics (STEM) > Life, Health and Chemical Sciences
Faculty of Science, Technology, Engineering and Mathematics (STEM) - Depositing User
- Sotiris Missailidis